High-pro­file biotech leader Deb­o­rah Dun­sire takes the helm at XTu­it, fo­cused on can­cer and fi­bro­sis

Deb­o­rah Dun­sire is back in biotech.
About nine months af­ter Dun­sire left a fast-sink­ing Fo­rum Phar­ma­ceu­ti­cals, she’s tak­en the helm of a biotech start­up with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.